<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Synthesis and biological activities of [N-MeLeu5] didemnin B
2
Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors
3
Synthesis and biological activities of 2′-deoxy-2′-fluoro-4′-thioarabinofuranosylpyrimidine and -purine nucleosides Original Research Article
4
Synthesis and biological activities of 2-methyl-4-N-2́-cyanoethyl-N-substituted benzaldehydes and their derivatives
5
Synthesis and biological activities of 2-oxocycloalkylsulfonamides Original Research Article
6
Synthesis and biological activities of 3-polyamino-5β-cholane-7α,24-diols
7
Synthesis and biological activities of 5′-ethylenic and acetylenic modified l-nucleosides and isonucleosides
8
Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring Original Research Article
9
Synthesis and biological activities of a novel class of azole-containing antifungal agents
10
Synthesis and biological activities of an α-methyl and a β-methyl carbapenem and the corresponding unsubstituted compound
11
Synthesis and biological activities of analogs of d-glucosyl-l-tyrosine, a humoral factor that stimulates transcription of the acyl-CoA binding protein in the pheromone gland of the Silkmoth, Bombyx mori Original Research Article
12
Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2
13
Synthesis and biological activities of camphor-based non-peptide growth hormone secretagogues
14
Synthesis and biological activities of flavolipids
15
Synthesis and biological activities of fluorinated 10-hydroxycamptothecin and SN38
16
Synthesis and biological activities of fluorinated chalcone derivatives Original Research Article
17
Synthesis and biological activities of fluorine-containing N,N′-diphenylcarbamimidothioates
18
Synthesis and biological activities of glycosphingolipid analogues from marine sponge Aplysinella rhax
19
Synthesis and biological activities of hapalosin derivatives with modification at the C12 position
20
Synthesis and biological activities of hydroxyl-protected fluorine-containing 4,4-dihydroxylmethyl-2-aryl-iminothiazolidines
21
Synthesis and biological activities of isogranulatimide analogues Original Research Article
22
Synthesis and Biological Activities of Lipid A Analogs Possessing (beta)-Glycosidic Linkage at 1-Position
23
Synthesis and biological activities of lipid A-type pyrancarboxylic acid derivatives
24
Synthesis and biological activities of methylenebis-4H-1,2,4-triazole derivatives
25
Synthesis and biological activities of N-(1,2,4-triazole-4-yl)-N′-(fluorine-containing-phenyl)carbamimidothioates
26
Synthesis and biological activities of NB-506 analogues modified at the glucose group
27
Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings
28
Synthesis and biological activities of new 1H-1,2,4-triazole derivatives containing ferrocenyl moiety
29
Synthesis and biological activities of new 1α,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain Original Research Article
30
Synthesis and biological activities of new conformationally fixed analogues of (−)-indolactam-V, the core structure of tumor-promoting teleocidins
31
Synthesis and biological activities of new heterocyclic aromatic retinoids
32
Synthesis and Biological Activities of Nickel(II) and Cadmium(II) Complexes of Chlorohydroxyacetophenone-nitrobenzoylhydrazone: Mechanism for Formation of the Nickel(II) complex
33
Synthesis and biological activities of novel 17-aminogeldanamycin derivatives Original Research Article
34
Synthesis and biological activities of novel 4″-alkylidene avermectin derivatives
35
Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action Original Research Article
36
Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists
37
Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates
38
Synthesis and biological activities of novel dialkyl (4-trifluoromethylphenylamino)-(4-trifluoromethyl or 3-fluorophenyl) methylphosphonates
39
Synthesis and biological activities of novel isoxazoline-linked pseudodisaccharide derivatives Original Research Article
40
Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring Original Research Article
41
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand
42
Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors
43
Synthesis and biological activities of nucleoside–estradiol conjugates
44
Synthesis and biological activities of octyl 2,3,4-tri-O-sulfo-α-l-fucopyranosyl-(1 → 3)-2,4-di-O-sulfo-α-l-fucopyranosyl-(1 → 3)-2,4-di-O-sulfo-α-l-fucopyranosyl-(1 → 3)-2,4-di-O-sulfo-β-l-fucopyranoside Original Research Article
45
Synthesis and biological activities of octyl 2,3-di-O-sulfo-α-l-fucopyranosyl-(1 → 3)-2-O-sulfo-α-l-fucopyranosyl-(1 → 4)-2,3-di-O-sulfo-α-l-fucopyranosyl-(1 → 3)-2-O-sulfo-α-l-fucopyranosyl-(1 → 4)-2,3-di-O-sulfo-β-l-fucopyranoside Original Research Arti
46
Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues
47
Synthesis and biological activities of phenylahistin derivatives Original Research Article
48
Synthesis and biological activities of phthalocyanine–estradiol conjugates
49
Synthesis and biological activities of position one and three transposed analogs of the opioid peptide YKFA
50
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz
51
Synthesis and biological activities of quinazoline derivatives with ortho-phenol-quaternary ammonium salt groups Original Research Article
52
Synthesis and biological activities of quinazoline derivatives with ortho-phenol-quaternary ammonium salt groups Original Research Article
53
Synthesis and biological activities of reveromycin A and spirofungin A derivatives
54
Synthesis and Biological Activities of Some Benzimidazoles Derivatives
55
Synthesis and Biological Activities of Some New Derivatives Based on 5-Styryl-2-amino-1,3,4-thiadiazole
56
Synthesis and biological activities of some new dibenzopyranones and dibenzopyrans: search for potential oestrogen receptor agonists and antagonists Original Research Article
57
Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues
58
Synthesis and biological activities of the tris-oxazole macrolactone analogs of mycalolides
59
Synthesis and biological activities of three sulfated sialyl Lex ganglioside analogues for clarifying the real carbohydrate ligand structure of L-selectin Original Research Article
60
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506
61
Synthesis and biological activities of truncated acridone: Structure-activity relationship studies of cytotoxic 5-hydroxy-4-quinolone
62
Synthesis and biological activities of ykfa analogues: effects of position 4 substitutions and altered ring size on In vitro opioid activity
63
Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin
64
Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide
65
Synthesis and biological activity of [Tic5] didemnin B
66
Synthesis and biological activity of 1,2,3,4-tetrahydroquinoline and 3,4-(1H)-dihydroquinolin-2-one analogs of retinoic acid
67
Synthesis and biological activity of 1-alkylcarbonylmethyl analogues of YM022
68
Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors Original Research Article
69
Synthesis and Biological Activity of 1-Phenylsulfonyl-4-Phenylsulfonylaminopyrrolidine Derivatives as Thromboxane A2 Receptor Antagonists Original Research Article
70
Synthesis and biological activity of 1β-methyl-2-[5′-isoxazoloethenylpyrrolidin-3′-ylthio]carbapenems
71
Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives Original Research Article
72
Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1α,25-dihydroxyvitamin D3 Original Research Article
73
Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues
74
Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues
75
Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y1 receptor antagonists Original Research Article
76
Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists
77
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors
78
Synthesis and biological activity of 2-Carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes
79
Synthesis and biological activity of 2-methyl-20-epi analogues of 1α,25-dihydroxyvitamin D3
80
Synthesis and biological activity of 3,3-Diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cells Original Research Article
81
Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers
82
Synthesis and biological activity of 3-hydroxy(phosphono)methyl-bearing phosphatidylinositol ether lipid analogues
83
Synthesis and biological activity of 3-substituted 3-desoxynaltrindole derivatives
84
Synthesis and biological activity of 4′,8-dihydroxyisoflavon-7-yl d-hexopyranosides
85
Synthesis and biological activity of 4′-azido- and 4′-trifluoracetamido-3′-chloro-3′-deamino-4′-deoxydaunorubicin
86
Synthesis and biological activity of 4′-methoxy derivatives of abscisic acid
87
Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of p-glycoprotein-mediated multidrug resistance Original Research Article
88
synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane a2 receptor antagonists Original Research Article
89
Synthesis and biological activity of 5-[(2,5-dihydroxybenzyl)amino]salicylic acid analogs as inhibitors of EGF receptor-associated protein tyrosine kinase
90
Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors
91
Synthesis and biological activity of 5-aza-ellipticine derivatives
92
Synthesis and biological activity of 5-heteroaryl benzodiazepines: analogues of YM022
93
Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators
94
Synthesis and biological activity of 5-substituted-2-amino-1,3,4-oxadiazole derivatives
95
Synthesis and biological activity of 8β-substituted hydrocodone indole and hydromorphone indole derivatives
96
Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase
97
Synthesis and biological activity of a new anti-factor Xa pentasaccharide with a C-interglycosidic bond
98
Synthesis and Biological Activity of a New Pt(II) Complex Involving 4-bromo-2,6-bis-hydroxymethyl-phenol and Nicotinamide
99
Synthesis and Biological Activity of a New Schiff Base Ligand Pyridazine Based
100
Synthesis and biological activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7
101
Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B) Original Research Article
102
Synthesis and biological activity of a novel series of indole-derived PPARγ agonists
103
Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738
104
Synthesis and biological activity of a series of 4-aryl substituted benz[b]azepines: Antagonists at the strychnine-insensitive glycine site
105
Synthesis and biological activity of a stereoisomeric mixture of the mating hormone of Phytophthora
106
Synthesis and biological activity of amide derivatives of nimbolide
107
Synthesis and biological activity of analogues of batzelladine F
108
Synthesis and biological activity of analogues of ptilomycalin A
109
Synthesis and biological activity of A-nor-paclitaxel analogues Original Research Article
110
Synthesis and biological activity of anthelmintic thiadiazoles using an AF-2 receptor binding assay
111
Synthesis and biological activity of anticoccidial agents: 5,6-Diarylimidazo[2,1-b][1,3]thiazoles
112
Synthesis and biological activity of artificial analogs of mycalamide A
113
Synthesis and Biological Activity of C-6 and C-7 Modified Paclitaxels
114
Synthesis and Biological Activity of Certain Mannich Bases Derivatives from 1, 2, 4-Triazoles
115
Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors
116
Synthesis and biological activity of conformationally constrained sialyl Lewis X analogues with reduced carbohydrate character
117
Synthesis and biological activity of conformationally restricted gypsy moth pheromone mimics Original Research Article
118
Synthesis and biological activity of conformationally restricted tricyclic analogs of the hormone melatonin
119
Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin
120
Synthesis and biological activity of copper(II) mixed ligand complexes with thiophene-2-aldehyde thiosemicarbazone as the primary ligand
121
Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists
122
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 Original Research Article
123
Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors
124
Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2′-Substituted triclosan derivatives
125
Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners
126
Synthesis and biological activity of enantiomeric pairs of 5-vinylthiolactomycin congeners
127
Synthesis and biological activity of enantiomers of a conformationally restricted muscarone analog
128
Synthesis and biological activity of ester and ether analogues of α-galactosylceramide (KRN7000) Original Research Article
129
Synthesis and biological activity of ferrocenyl derivatives of the non-steroidal antiandrogens flutamide and bicalutamide
130
Synthesis and biological activity of fluorinated 2-amino-4-aryl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazoles
131
Synthesis and biological activity of fluorinated 7-aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amines
132
Synthesis and biological activity of fluoroquinolone-pyrrolo[2,1-c][1,4]benzodiazepine conjugates Original Research Article
133
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
134
Synthesis and biological activity of glutamic acid derivatives
135
Synthesis and biological activity of high-affinity retinoic acid receptor antagonists Original Research Article
136
Synthesis and biological activity of hydroxylated analogs of RCAI-80
137
Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide) Original Research Article
138
Synthesis and biological activity of isopentenyl diphosphate analogues Original Research Article
139
Synthesis and biological activity of isoprenoid bisphosphonates Original Research Article
140
Synthesis and biological activity of J-104,118, a novel, potent inhibitor of squalene synthase
141
Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: Preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods
142
Synthesis and biological activity of KCB-328 and its analogues: Novel class III antiarrhythmic agents with little reverse frequency dependence
143
Synthesis and biological activity of lactones en route to Altohyrtin A
144
Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease
145
Synthesis and biological activity of macrocyclic taxane analogues
146
Synthesis and biological activity of medium molecular weight polymers of camptothecin
147
Synthesis and Biological Activity of Methanesulfonamide Pyrimidine- and N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-heptenoates, a Novel Series of HMG-CoA Reductase Inhibitors Original Research Article
148
Synthesis and biological activity of mustard derivatives of combretastatins
149
Synthesis and biological activity of N,N-dialkylaminoalkyl-substituted bisindolyl and diphenyl pyrazolone derivatives Original Research Article
150
Synthesis and biological activity of N4-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents Original Research Article
151
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin
152
Synthesis and biological activity of naphthalene analogues of phenstatins: Naphthylphenstatins
153
Synthesis and biological activity of N-aroyl-tetrahydro-γ-carbolines Original Research Article
154
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases
155
Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for α1-adrenoceptor antagonists Original Research Article
156
Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics
157
Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system Original Research Article
158
Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacers
159
Synthesis and biological activity of new melatonin dimeric derivatives Original Research Article
160
Synthesis and biological activity of new quinoxaline antibiotics of echinomycin analogues
161
Synthesis and Biological Activity of New Series of N-[3-(1H-1,2,3-Benzotriazol-1-yl)propyl]-2-(substituted Phenyl)-3-Chloro-4-Oxo-1-Azetidinecarboxamide
162
Synthesis and biological activity of N-methylated analogs of endomorphin-2 Original Research Article
163
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids Original Research Article
164
Synthesis and biological activity of nociceptin/orphanin FQ(1–13)NH2 analogues modified in 9 and/or 13 position
165
Synthesis and biological activity of novel 1,2-disubstituted benzene derivatives as factor Xa inhibitors Original Research Article
166
Synthesis and biological activity of novel 1,4-diazepane derivatives as factor Xa inhibitor with potent anticoagulant and antithrombotic activity Original Research Article
167
Synthesis and biological activity of novel 1β-Methylcarbapenems with oxyiminopyrrolidinylamide moiety
168
Synthesis and biological activity of novel 2-(3-trifluoromethylphenoxy)-4-trifluoromethylthiazole-5-carboxamide derivatives
169
Synthesis and biological activity of novel 2-methyl-4-trifluoromethyl-thiazole-5-carboxamide derivatives
170
Synthesis and biological activity of novel 3-(4-methylthio benzene sulfonyl)-2,4-dimethyl/2,4-diphenyl/4-methyl-2-phenyl/2-ethoxy-4-methyl/ 2, 4-diethoxy–1,5-benzothiazepines
171
Synthesis and biological activity of novel 3′-trifluoromethyl taxoids
172
Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor Original Research Article
173
Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: Potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility
174
Synthesis and biological activity of novel antibacterial quinazolines
175
Synthesis and biological activity of novel cyanoacrylates containing ferrocenyl moiety
176
Synthesis and biological activity of novel macrocyclic antifungals: acylated conjugates of the ornithine moiety of the lipopeptidolactone FR901469
177
Synthesis and biological activity of novel macrocyclic antifungals: modification of the tyrosine moiety of the lipopeptidolactone FR901469
178
Synthesis and biological activity of novel N′-tert-butyl-N′-substituted benzoyl-N-(substituted phenyl)aminocarbonylhydrazines and their derivatives
179
Synthesis and Biological Activity of Novel Neuroprotective Diketopiperazines Original Research Article
180
Synthesis and biological activity of novel penem sulfoxides and sulfones
181
Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists
182
Synthesis and biological activity of novel platinum(II) complexes of glutamate tethered to hydrophilic hematoporphyrin derivatives
183
Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors
184
Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives Original Research Article
185
Synthesis and biological activity of novel series of 4-methoxy, and 4,9-dimethoxy-5-substituted furo[2,3-g]-1,2,3-benzoxathiazine-7,7-dioxide derivatives
186
Synthesis and biological activity of novel sialyl-lewisX conjugates
187
Synthesis and biological activity of novel thiazolidin-4-ones with a carbohydrate moiety Original Research Article
188
Synthesis and biological activity of novel thiazolidinediones
189
Synthesis and biological activity of novel thyroid hormone analogues: 5′-aryl substituted GC-1 derivatives Original Research Article
190
Synthesis and biological activity of novel tricyclic β-lactams
191
Synthesis and biological activity of novel α-substituted β-phenylpropionic acids having pyridin-2-ylphenyl moiety as antihyperglycemic agents Original Research Article
192
Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists Original Research Article
193
Synthesis and biological activity of olomoucine II
194
Synthesis and biological activity of oxo-7H-benzo[e]perimidine-4-carboxylic acid derivatives as potent, nonpeptide corticotropin releasing factor (CRF) receptor antagonists
195
Synthesis and biological activity of P2–P4 azapeptidomimetic P1-argininal and P1-ketoargininamide derivatives: a novel class of serine protease inhibitors
196
Synthesis and biological activity of Para-substituted 3′-phenyl docetaxel analogs
197
Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors
198
Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to -thyronine
199
Synthesis and biological activity of phosphatidylinositol-3,4,5-trisphosphorothioate
200
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors
201
Synthesis and biological activity of piperazine-Based dual MMP-13 and TNF-α converting enzyme inhibitors
202
Synthesis and biological activity of polygalloyl-dendrimers as stable tannic acid mimics
203
Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1
204
Synthesis and biological activity of previtamin D3 analogues with A-ring modifications Original Research Article
205
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors
206
Synthesis and biological activity of retinoic acid receptor-α specific amides
207
Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety Original Research Article
208
Synthesis and biological activity of selective azasugar-based TACE inhibitors
209
Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitors
210
Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors Original Research Article
211
Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90)
212
Synthesis and biological activity of siRNA and Etoposide with magnetic nanoparticles on drug resistance model MCF-7 Cells: Molecular docking study with MRP1 enzyme
213
Synthesis and biological activity of some 3-acryloxymethyl cephalosporins
214
SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME BARBITURIC ACID DERIVATIVES VIA SCHIFF΄ S BASES
215
Synthesis and biological activity of some known and putative duloxetine metabolites
216
Synthesis and Biological Activity of Some New 5-Sulphanyl- 4-nitroimidazole Derivatives
217
Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones Original Research Article
218
Synthesis and Biological activity of Some PyrroloPyrimidine Compounds
219
Synthesis and Biological activity of Some PyrroloPyrimidine Compounds
220
Synthesis and biological activity of some rigid analogues of flavone-8-acetic acid Original Research Article
221
Synthesis and biological activity of some structural modifications of pancratistatin
222
Synthesis and biological activity of some sulphonamoylazopyrazoles
223
Synthesis and biological activity of S-oxo-[(methylthio)-methyl]cysteinols
224
Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage Original Research Article
225
Synthesis and biological activity of substituted 3-fluoro/3-trifluoromethyl 10H-phenothiazines, its ribofuranosides and sulfones
226
Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers
227
Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors Original Research Article
228
Synthesis and biological activity of the 1α,25-dihydroxyvitamin D3 diastereomer with unnatural configuration at the rings C/D side-chain moiety
229
Synthesis and biological activity of the first cyclic biphalin analogues
230
Synthesis and biological activity of the neuronal calcium channel blocker 2-amino-1-(2,5-dimethoxyphenyl)-5-trifluoromethyl benzimidazole (NS-649)
231
Synthesis and biological activity of the new 5-fluorocytosine derivatives, 5′-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-5′-carboxylic acid
232
Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives
233
Synthesis and biological activity of trans-2,3-dihydroraloxifene
234
Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones Original Research Article
235
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
236
Synthesis and Biological Activity of Water-Soluble Maleimide Derivatives of the Anticancer Drug Carboplatin Designed as Albumin-Binding Prodrugs
237
Synthesis and biological activity of α,β,γ,δ-unsaturated aldehydes from diatoms
238
Synthesis and biological activity of α-aminoboronic acids, amine-carboxyboranes and their derivatives
239
Synthesis and biological activity of β-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPT Original Research Article
240
Synthesis and biological activity research of novel ferrocenyl-containing thiazole imine derivatives
241
Synthesis and Biological Activity Study of New Some Schiff Bases Derived From D-Erythroascorbic Acid
242
Synthesis and Biological Activity study of some New Isonicotinic Acid Hydrazide (isoniazid) Derivatives
243
Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: Further validation of a pharmacophore model for α1-adrenoceptor antagonists
244
Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin Original Research Article
245
Synthesis and Biological Assessment of 2-Hydroxyiminoethanones as Anti- Inflammatory and β-Amyloid Aggregation Inhibitors
246
Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties
247
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer
248
Synthesis and biological characterization of AQPazide, a novel biotinylated photoaffinity probe for the study of the human platelet throm☐ane A2 receptor
249
Synthesis and biological characterization of novel hybrid 7-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors Original Research Article
250
Synthesis and biological characterization of stable and radioiodinated (±)-trans-2-hydroxy-3P{4-(3-iodophenyl)piperidyl}-1,2,3,4-tetrahydronaphthalene (3-IBVM)
251
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands
252
Synthesis and Biological Effectiveness of Some new Azo Compounds as Derivatives of Nitrogen Bases
253
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor
254
Synthesis and biological evaluation of - and -configuration 1,3-dioxolane 5-azacytosine and 6-azathymine nucleosides
255
Synthesis and biological evaluation of - and -configurations of 2′,3′-dideoxy-4′-c-methyl-3′-oxacytidine analogues
256
Synthesis and biological evaluation of (−)-dictyostatin and stereoisomers
257
Synthesis and biological evaluation of (−)-laulimalide analogues
258
Synthesis and biological evaluation of (±)-cryptotanshinone and its simplified analogues as potent CDC25 inhibitors
259
Synthesis and biological evaluation of (2S)- and (2R)-2-(3′-phosphonobicyclo[1.1.1]pentyl)glycines as novel group III selective metabotropic glutamate receptor ligands
260
Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents Original Research Article
261
Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT2A receptor antagonists Original Research Article
262
Synthesis and biological evaluation of (R)-N-(diarylmethylthio/sulfinyl)ethyl/propyl-piperidine-3-carboxylic acid hydrochlorides as novel GABA uptake inhibitors
263
Synthesis and biological evaluation of [4-(2-phenylethenesulfonylmethyl)phenyl]-quinazolin-4-yl-amines as orally active anti-cancer agents
264
Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors
265
Synthesis and biological evaluation of 1-(4-[18f]fluorobenzyl)-4-[(5,6-dimethoxy-1-oxoindan2-yl)methyl]piperidine for in vivo studies of acetylcholinesterase
266
Synthesis and biological evaluation of 1-(benzenesulfonamido)-2-[5-(N-hydroxypyridin-2(1H)-one)]acetylene regioisomers: A novel class of 5-lipoxygenase inhibitors
267
Synthesis and biological evaluation of 1,1-Dichloro-2,3-diarylcyclopropanes as antitubulin and anti-breast cancer agents Original Research Article
268
Synthesis and biological evaluation of 1,1-difluoro-2-(tetrahydro-3-furanyl)ethylphosphonic acids possessing a N9-purinylmethyl functional group at the ring. A new class of inhibitors for purine nucleoside phosphorylases
269
Synthesis and biological evaluation of 1,2-disubstituted carbonucleosides of 2-amino-6-substituted purine and 8-azapurine
270
Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors
271
Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors Original Research Article
272
Synthesis and biological evaluation of 1,3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipoxygenases
273
Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure Original Research Article
274
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors Original Research Article
275
Synthesis and biological evaluation of 11C-labeled β-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging Original Research Article
276
Synthesis and biological evaluation of 12 allenic aromatic ethers
277
Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: Investigating the hypothesis of shared structure–activity relationships Original Research Article
278
Synthesis and biological evaluation of 14,15-dehydro-LTA4 analog
279
Synthesis and biological evaluation of 14-alkoxymorphinans. 14.1 14-ethoxy-5-methyl substituted indolomorphinans with δ opioid receptor selectivity
280
Synthesis and biological evaluation of 14-alkoxymorphinans.12.1 A phenethyl analogue of the μ-selective opioid receptor antagonist cyprodime
281
Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase
282
Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: new dopamine transporter inhibitors
283
Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor
284
Synthesis and biological evaluation of 1α,24-dihydroxy-25-nitrovitamin D3
285
Synthesis and biological evaluation of 1α-hydroxy-25(R and S)-25,26-Epoxy-23-yne vitamin D3 and of 1α,25(R and S),26-Trihydroxy-23-yne vitamin D3
286
Synthesis and biological evaluation of 2-(3′,4′,5′-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization Original Research Article
287
Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profile Original Research Article
288
Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720
289
Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer Original Research Article
290
Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors Original Research Article
291
Synthesis and biological evaluation of 2,3-diarylthiophenes as selective Cox-2 and Cox-1 inhibitors
292
Synthesis and biological evaluation of 2,3-diarylthiophenes as selective cox-2 inhibitors. part II: Replacing the heterocycle
293
Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties
294
Synthesis and biological evaluation of 2,6-di-tert-butylphenol hydrazones as 5-lipoxygenase inhibitors Original Research Article
295
Synthesis and biological evaluation of 2,7-Dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione derivatives, a novel group of anticancer agents active on a multidrug resistant cell line Original Research Article
296
Synthesis and biological evaluation of 2,8-disubstituted 9-benzyladenines: discovery of 8-mercaptoadenines as potent interferon-inducers Original Research Article
297
Synthesis and biological evaluation of 2′,5′-dimethoxychalcone derivatives as microtubule-targeted anticancer agents Original Research Article
298
Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase Original Research Article
299
Synthesis and biological evaluation of 2-amino-2-deoxy- and 6-amino-6-deoxy-cyclomaltoheptaose polysulfates as synergists for angiogenesis inhibition Original Research Article
300
Synthesis and biological evaluation of 2-amino-3-(3′,4′,5′-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization
301
Synthesis and Biological Evaluation of 2-Aminothiazole Analogues of Nα-Protected Amino Acids
302
Synthesis and biological evaluation of 2-aminothiazoles and their amide derivatives on human adenosine receptors. Lack of effect of 2-aminothiazoles as allosteric enhancers Original Research Article
303
Synthesis and biological evaluation of 2-Hydroxy derivatives of digitoxigenin and 3-Epidigitoxigenin Original Research Article
304
Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent
305
Synthesis and biological evaluation of 2-methoxy- and 2-Methylthio-6-[(2′-alkylamino)ethyl]-4(3H)-pyrimidinones with anti-rubella virus activity Original Research Article
306
Synthesis and Biological Evaluation of 2-Phenyl Benzothiazole Derivatives as Cytotoxic Agents
307
Synthesis and biological evaluation of 2-thiopyrimidine derivatives Original Research Article
308
Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles: A novel class of cyclooxygenase-2 inhibitors Original Research Article
309
Synthesis and biological evaluation of 2β,3α-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents
310
Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives Original Research Article
311
Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents Original Research Article
312
Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors
313
Synthesis and biological evaluation of 3′,4′,5′-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation Original Research Article
314
Synthesis and biological evaluation of 3′-Carboranyl thymidine analogues
315
Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents
316
Synthesis and biological evaluation of 3-aryltyramines as fragments binding to BACE-1 and BACE-2
317
Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS
318
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors
319
Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors
320
Synthesis and biological evaluation of 3-substituted4-[2-(4"-isobutylphenyl)propionamido]-5-mercapto-l, 2,4-triazoles and their derivatives
321
Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors Original Research Article
322
Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV Original Research Article
323
Synthesis and biological evaluation of 4-[(3-Methyl-3H-imidazol-4-yl)-(2-phenylethynyl-benzyloxy)-methyl]-benzonitrile as novel farnesyltransferase inhibitor
324
Synthesis and biological evaluation of 4-[3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-benzonitrile as novel farnesyltransferase inhibitor
325
Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors
326
Synthesis and biological evaluation of 4-alkoxy substituted trinems. Part I
327
Synthesis and biological evaluation of 4-alkoxysubstituted trinems. Part II
328
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors
329
Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase Original Research Article
330
Synthesis and biological evaluation of 4-Deacetoxy-1,7-dideoxy azetidine paclitaxel analogues
331
Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors Original Research Article
332
Synthesis and biological evaluation of 4-heterotribactams
333
Synthesis and Biological Evaluation of 4-hydroxychromenyl arylmethyl-6- hydroxy pyrimidine-2, 4-dione Derivatives
334
Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors
335
Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors Original Research Article
336
Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-β type1 receptor kinase inhibitors
337
Synthesis and biological evaluation of 5,6-diarylimidazo[2.1-b]thiazole as selective COX-2 inhibitors
338
Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors
339
Synthesis and biological evaluation of 5′-O-dicarboxylic fatty acyl monoester derivatives of anti-HIV nucleoside reverse transcriptase inhibitors
340
Synthesis and biological evaluation of 5-arylamino-1H-benzo[d]imidazole-4,7-diones as inhibitor of endothelial cell proliferation Original Research Article
341
Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt
342
Synthesis and biological evaluation of 5R- and 5S-methyl substituted d- and l-configuration 1,3-dioxolane nucleoside analogs Original Research Article
343
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitors
344
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists Original Research Article
345
Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors
346
Synthesis and biological evaluation of 6′,7′-dihydroxybergamottin (6,7-DHB), a naturally occurring inhibitor of cytochrome P450 3A4
347
Synthesis and biological evaluation of 6-aryl-6H-pyrrolo[3,4-d]pyridazine derivatives as high-affinity ligands of the α2δ subunit of voltage-gated calcium channels
348
Synthesis and biological evaluation of 6-aryl-6H-pyrrolo[3,4-d]pyridazine derivatives: high-affinity ligands to the α2δ subunit of voltage gated calcium channels
349
Synthesis and biological evaluation of 6-oxa-nor-tropane glycomimetics as glycosidase inhibitors
350
Synthesis and biological evaluation of 7-azaindole derivatives, synthetic cytokinin analogues
351
Synthesis and biological evaluation of 7-azaindolocarbazoles
352
Synthesis and biological evaluation of 9-(5′,5′-difluoro-5′-phosphonopentyl)guanine derivatives for PNP-inhibitors Original Research Article
353
Synthesis and biological evaluation of 99mTc(CO)3-OH-PP-CS2 for brain receptor imaging
354
Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for β-amyloid plaques in the brain
355
Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP
356
Synthesis and biological evaluation of 9-substituted tetracycline derivatives
357
Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library Original Research Article
358
Synthesis and biological evaluation of a bicyclo [7.4.1]enediyne
359
Synthesis and biological evaluation of a C5-biphenyl thiolactomycin library
360
Synthesis and biological evaluation of a conformationally free seco-analogue of the immunosuppressant FR901483 Original Research Article
361
Synthesis and biological evaluation of a des-dihydropyran laulimalide analog
362
SYNTHESIS AND BIOLOGICAL EVALUATION OF A FLUORINATED ANALOG OF THE β-ADRENERGIC BLOCKING AGENT, METOPROLOL
363
Synthesis and biological evaluation of a focused library of beauveriolides
364
Synthesis and Biological Evaluation of a New Benzofuran Analogue of 8-HETE
365
Synthesis and biological evaluation of a new class of bryostatin analogues: the role of the C20 substituent in protein kinase C binding
366
Synthesis and biological evaluation of a new class of bryostatin analogues: the role of the C20 substituent in protein kinase C binding
367
Synthesis and biological evaluation of a new class of bryostatin analogues: the role of the C20 substituent in protein kinase C binding
368
Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)
369
Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase Original Research Article
370
Synthesis and biological evaluation of a new series of dihydrofolate reductase inhibitors based on the 4-(2,6-diamino-5-pyrimidinyl)alkyl-L-glutamic acid structure
371
Synthesis and biological evaluation of a novel decadentate ligand DEPA
372
Synthesis and biological evaluation of a novel Glucosylated Derivative of Gadolinium Diethylenetriaminepentaacetic acid for Tumor Magnetic Resonance Imaging
373
Synthesis and biological evaluation of a novel phenyl substituted sydnone series as potential antitumor agents
374
SYNTHESIS and BIOLOGICAL EVALUATION OF A NOVEL SERIES OF 2-(4-CHLORO-3-METHYLPHENOXY)ACETYL AMINO ACIDS and PEPTIDES
375
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents Original Research Article
376
Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonists
377
Synthesis and biological evaluation of a radiolabeled analog of methyl 2-acetamido-2,4-dideoxy-β-d-xylo-hexopyranoside directed towards influencing cellular glycosaminoglycan biosynthesis Original Research Article
378
Synthesis and biological evaluation of a series of 2′-fluorinated-2′,3′-dideoxy-2′,3′-didehydro-( )-nucleosides
379
Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives
380
Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1) Original Research Article
381
Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter
382
Synthesis and biological evaluation of a sialyl lewis X mimic with significantly improved E-selectin inhibition
383
Synthesis and biological evaluation of a small library of nojirimycin-derived bicyclic iminosugars Original Research Article
384
Synthesis and biological evaluation of a spongistatin AB-spiroketal analogue
385
Synthesis and biological evaluation of a technetium-99m(I)-tricarbonyl-labelled phenyltropane derivative
386
Synthesis and biological evaluation of a water soluble phosphate prodrug of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP)
387
Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: Dual inhibitors of cyclooxygenases and lipoxygenases Original Research Article
388
Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors Original Research Article
389
Synthesis and biological evaluation of alkoxycoumarins as novel nematicidal constituents
390
Synthesis and biological evaluation of all A-ring stereoisomers of 5,6-trans-2-methyl-1,25-dihydroxyvitamin D3 and their 20-epimers: possible binding modes of potent A-ring analogues to vitamin D receptor Original Research Article
391
Synthesis and biological evaluation of allenic quinazolines using palladium-catalyzed hydride-transfer reaction
392
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production
393
Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging
394
Synthesis and biological evaluation of an alkenyldiarylmethane (ADAM) which acts as a novel non-nucleoside HIV-1 reverse transcriptase inhibitor
395
Synthesis and biological evaluation of an electronically activated isooxacephem Original Research Article
396
Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug
397
Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats
398
Synthesis and biological evaluation of analogs of altohyrtin C (spongistatin 2)
399
Synthesis and biological evaluation of analogs of the marine toxin polycavernoside A
400
Synthesis and biological evaluation of analogues of bacterial lipid I
401
Synthesis and biological evaluation of analogues of the anti-tumor alkaloid naamidine A
402
Synthesis and biological evaluation of antitumor-active γ-butyrolactone substituted betulin derivatives Original Research Article
403
Synthesis and biological evaluation of antitumour-active betulin derivatives Original Research Article
404
Synthesis and biological evaluation of a-Ring biaryl-carbamate analogues of rhazinilam Original Research Article
405
Synthesis and biological evaluation of aristolactams
406
Synthesis and biological evaluation of aromatic enones related to curcumin Original Research Article
407
Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na+/H+ exchanger Original Research Article
408
Synthesis and biological evaluation of aryl azide derivatives of combretastatin a-4 as molecular probes for tubulin Original Research Article
409
Synthesis and biological evaluation of asymmetric gramicidin S analogues containing modified d-phenylalanine residues Original Research Article
410
Synthesis and biological evaluation of aziridine-containing analogs of phytosphingosine
411
Synthesis and biological evaluation of bengacarboline derivatives
412
Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases
413
Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase
414
Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials
415
Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators Original Research Article
416
Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation
417
Synthesis and biological evaluation of benzo[b]naphthyridones, a series of new topical antibacterial agents
418
Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists Original Research Article
419
Synthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophores Original Research Article
420
Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents
421
Synthesis and biological evaluation of bicyclic and tricyclic substituted nortropane derivatives: discovery of a novel selective α1D-adrenergic receptor ligand Original Research Article
422
Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents
423
Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors
424
Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins Original Research Article
425
Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2
426
Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3′-C-ethynyluridine (EUrd) and 3′-C-ethynylcytidine (ECyd) Original Research Article
427
Synthesis and biological evaluation of B-ring analogues of (−)-rhazinilam Original Research Article
428
Synthesis and biological evaluation of B-ring modified colchicine and isocolchicine analogs
429
Synthesis and biological evaluation of bryostatin analogues: the role of the A-ring
430
Synthesis and biological evaluation of C-12′ substituted vinflunine derivatives
431
Synthesis and biological evaluation of carboacyclic nucleosides with (Z) and (E)-9-[4,4-bis(hydroxymethyl)]-2-butenyl side chain Original Research Article
432
Synthesis and biological evaluation of carbohydrate appended hydrazinocyclopentenes with potent glycation and α-glucosidase inhibition activities
433
Synthesis and biological evaluation of cepharadiones A and B and related dioxoaporphines Original Research Article
434
SYNTHESIS AND BIOLOGICAL EVALUATION OF CERTAIN 2H-PYRAN-2- ONES AND SOME DERIVED 1H-PYRIDIN-2-ONE ANALOGS AS ANTIMICROBIAL AGENTSa
435
Synthesis and Biological Evaluation of Certain New Substituted Pyrido[2,3-d]pyrimidin-4(1H)-one and Pyrido[2,3-d]triazolo[3,4-b]pyrimidine Analogs
436
Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents
437
Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3
438
Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors
439
Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents
440
Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors
441
Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5 Original Research Article
442
Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol Original Research Article
443
Synthesis and biological evaluation of conformationally constrained bicyclic and tricyclic balanol analogues as inhibitors of protein kinase C
444
Synthesis and biological evaluation of conformationally restricted gabapentin analogues
445
Synthesis and biological evaluation of copper (II) complexes of sterically hindered o-aminophenol derivatives as antimicrobial agents
446
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose
447
Synthesis and biological evaluation of cremastrine and an unnatural analogue
448
Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region)
449
Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction Original Research Article
450
Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor Original Research Article
451
Synthesis and biological evaluation of cyclopenta[c]thiophene related compounds as new antitumor agents Original Research Article
452
Synthesis and Biological Evaluation of Cyclophostin: A 5′,6″-Tethered Analog of Adenophostin A
453
Synthesis and Biological Evaluation of Cyclopropyl Analogs of the Antiestrogen MER 25
454
Synthesis and biological evaluation of cytostatin analogues
455
Synthesis and biological evaluation of cytotoxic activity of novel anthracene l-rhamnopyranosides Original Research Article
456
Synthesis and biological evaluation of deoxy salacinols, the role of polar substituents in the side chain on the α-glucosidase inhibitory activity Original Research Article
457
Synthesis and biological evaluation of deoxypreussomerin A and palmarumycin CP1 and related naphthoquinone spiroketals
458
Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity
459
Synthesis and biological evaluation of didemnin photoaffinity analogues
460
Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic Original Research Article
461
Synthesis and biological evaluation of dimeric cinnamaldehydes as potent antitumor agents Original Research Article
462
Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor Original Research Article
463
Synthesis and biological evaluation of DNA targeting flexible side-chain substituted β-carboline derivatives
464
Synthesis and biological evaluation of enantiopure thionitrites: The solid-phase synthesis and nitrosation of -glutathione as a molecular probe
465
Synthesis and biological evaluation of epothilone A dimeric compounds Original Research Article
466
Synthesis and biological evaluation of ether bridged bicyclic iminosugar derivatives Original Research Article
467
Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists
468
Synthesis and Biological Evaluation of Five- and Six-Membered Heterocycles as an Anti-Diabetic Agent: An Overview
469
Synthesis and biological evaluation of five-Membered heterocycles fused to cyclopenta[c]thiophene as new antitumor agents Original Research Article
470
Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptors Original Research Article
471
Synthesis and biological evaluation of flavonoids and related compounds as gastroprotective agents
472
Synthesis and Biological Evaluation of Flavonoids as Antiacetylcholinesterase Agent
473
Synthesis and biological evaluation of flavonoids as vasorelaxant agents
474
Synthesis and biological evaluation of fluorescently labeled epothilone analogs for tubulin binding studies
475
Synthesis and biological evaluation of fluorinated acyclothionucleosides
476
Synthesis and biological evaluation of four stereoisomers of PDMP-analogue, N-(2-decylamino-3-hydroxy-3-phenylprop-1-yl)-β-valienamine, and related compounds
477
Synthesis and biological evaluation of GABA derivatives able to cross the blood–Brain barrier in rats
478
Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria Original Research Article
479
Synthesis and biological evaluation of gambierol analogues
480
Synthesis and biological evaluation of gemcitabine–lipid conjugate (NEO6002)
481
Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to l-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase
482
Synthesis and biological evaluation of glycal-derived novel tetrahydrofuran 1,2,3-triazoles by ‘click’ chemistry Original Research Article
483
Synthesis and biological evaluation of glycosylated psoralen derivatives
484
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor Original Research Article
485
Synthesis and biological evaluation of helicid analogues as mushroom tyrosinase inhibitors
486
Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors
487
Synthesis and biological evaluation of highly potent analogues of epothilones B and D
488
Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: A cyclic tetrapeptide scaffold
489
Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyl group as dipeptidyl peptidase IV inhibitors
490
Synthesis and biological evaluation of homoserine lactone derived ureas as antagonists of bacterial quorum sensing Original Research Article
491
Synthesis and biological evaluation of hybrid molecules containing the pyrroloquinoline nucleus and DNA-minor groove binders
492
Synthesis and Biological Evaluation of Hydrazones fromNontraditional oils
493
Synthesis and biological evaluation of hydrophilic embelin derivatives
494
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II
495
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors Original Research Article
496
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors
497
Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents Original Research Article
498
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors Original Research Article
499
Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)
500
Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers Original Research Article
501
Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents Original Research Article
502
Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents Original Research Article
503
Synthesis and biological evaluation of isoflavone analogues from Dalbergia oliveri
504
Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities Original Research Article
505
Synthesis and biological evaluation of l-cysteine derivatives as mitotic kinesin Eg5 inhibitors
506
Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors Original Research Article
507
Synthesis and biological evaluation of lipophilic Ca1a2L analogues as potential bisubstrate inhibitors of protein:geranylgeranyl transferase-1 Original Research Article
508
Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes
509
Synthesis and biological evaluation of l-α-Phosphatidyl-d-3-deoxy-3-heteromethyl-myo-inositols as phosphoinositide 3-kinase inhibitors Original Research Article
510
Synthesis and Biological Evaluation of MAO-A Selective 1,4-Disubstituted-1,2,3,6-tetrahydropyridinyl Substrates Original Research Article
511
Synthesis and biological evaluation of menthol-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
512
Synthesis and biological evaluation of methoxylated analogs of the newer generation taxoids IDN5109 and IDN5390
513
Synthesis and biological evaluation of methoxyphenyl porphyrin derivatives as potential photodynamic agents Original Research Article
514
Synthesis and Biological Evaluation of Metronidazole Derivatives as Anti-Giardia Agents
515
Synthesis and biological evaluation of mixed ammine/amine platinum(II) complexes with dicarboxylate containing organic nitrate as ligand
516
Synthesis and biological evaluation of N-(1-aziridino)-6-fluoro-quinolone-3-carboxylic acids
517
Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol- 2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity
518
Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors Original Research Article
519
Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agents
520
Synthesis and biological evaluation of N-(aryl)-2-thiophen-2-ylacetamides series as a new class of antitubercular agents
521
Synthesis and biological evaluation of N-{4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl]benzoyl}-l-glutamic acid as a potential inhibitor of GAR Tfase and the de novo purine biosynthetic pathway Original Research Artic
522
Synthesis and biological evaluation of N-acetyl-β-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro
523
Synthesis and Biological Evaluation of New 1, 4-Dihydropyridines as Antihypertensives Agents in Rats
524
Synthesis and Biological Evaluation of New 1,4-Thiazine Containing Heterocyclic Compounds
525
Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity Original Research Article
526
Synthesis and biological evaluation of new 3,5-di(trifluoromethyl)-1,2,4-triazolesulfonylurea and thiourea derivatives as antidiabetic and antimicrobial agents
527
Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents Original Research Article
528
Synthesis and biological evaluation of new 3-trifluoromethylpyrazolesulfonyl-urea and thiourea derivatives as antidiabetic and antimicrobial agents
529
Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na+ and Ca2+ channel blockers with reduced affinity for dopamine D2 receptors Original Research Article
530
Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors Original Research Article
531
Synthesis and biological evaluation of new 4β-anilino- and 4β-imido-substituted podophyllotoxin congeners Original Research Article
532
Synthesis and biological evaluation of new 6-s-cis locked 1,2,25-trihydroxyprevitamin D3 analogues Original Research Article
533
Synthesis and biological evaluation of new antimalarial isonitriles related to marine diterpenoids
534
Synthesis and biological evaluation of new arylthiophene analogs of DuP 753
535
Synthesis and biological evaluation of new barbituric and thiobarbituric acid fluoro analogs of benzenesulfonamides as antidiabetic and antibacterial agents
536
Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers
537
Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer
538
Synthesis and biological evaluation of new conformationally biased integrin ligands based on a tetrahydroazoninone scaffold
539
Synthesis and biological evaluation of new derivatives of emodin Original Research Article
540
Synthesis and biological evaluation of new diisocyanide- and triisocyanide-99mTc complexes
541
Synthesis and biological evaluation of new dipyrrolo[3,4-a:3,4-c]carbazole-1,3,4,6-tetraones, substituted with various saturated and unsaturated side chains via palladium catalyzed cross-coupling reactions Original Research Article
542
Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3′,4′,5′-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents Original Research Article
543
Synthesis and biological evaluation of new mannose 6-phosphate analogues Original Research Article
544
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents Original Research Article
545
Synthesis and Biological Evaluation of New Nitroimidazole Derivatives as Anti-Helicobacter pylori Agents Against Metronidazole-Resistant Strains
546
Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series Original Research Article
547
Synthesis and biological evaluation of new oxime-ether derivatives of steroid as anti-bacterial agents
548
Synthesis and biological evaluation of new pyrazole- and tetrazole-related C-nucleosides with modified sugar moieties
549
Synthesis and biological evaluation of new pyridines containing imidazole moiety as antimicrobial and anticancer agents
550
Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin Original Research Article
551
Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers Original Research Article
552
Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J
553
Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists
554
Synthesis and biological evaluation of new tetrahydro-β-carbolines as inhibitors of the mitotic kinesin Eg5 Original Research Article
555
Synthesis and biological evaluation of new UDP-GalNAc analogues for the study of polypeptide-α-GalNAc-transferases
556
Synthesis and biological evaluation of N-heterocyclic carbene–silver(I) acetate complexes derived from 4,5-ditolyl-imidazole
557
Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis
558
Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors
559
Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers Original Research Article
560
Synthesis and Biological Evaluation of Nonionic Prenyl, Geranyl, and Farnesyl Diphosphate Surrogates
561
Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds
562
Synthesis and biological evaluation of nonpeptide mimetics of ω-conotoxin GVIA Original Research Article
563
Synthesis and biological evaluation of non-peptide αvβ3/α5β1 integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds Original Research Article
564
Synthesis and biological evaluation of non-polyene analogs of amphotericin B
565
Synthesis and biological evaluation of norcantharidin analogues: Towards PP1 selectivity Original Research Article
566
Synthesis and Biological Evaluation of Novel -2′-Azido-2′,3′-dideoxyarabinofuranosyl-4′-thiopyrimidines and purines
567
Synthesis and biological evaluation of novel (4 or 5-aryl)pyrazolyl-indoles as inhibitors of interleukin-2 inducible T-cell kinase (ITK) Original Research Article
568
Synthesis and biological evaluation of novel (l)-α-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents
569
Synthesis and biological evaluation of novel 1,3,5-triazine derivatives as antimicrobial agents
570
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents
571
Synthesis and biological evaluation of novel 1,5-benzothiazepin-4(5H)-ones as potent antiangiogenic and antioxidant agents
572
Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates
573
Synthesis and biological evaluation of novel 1β-methylcarbapenems having a new moiety at C-2
574
Synthesis and biological evaluation of novel 1β-methylcarbapenems with isothiazoloethenyl side chains
575
Synthesis and biological evaluation of novel 2-(1H-imidazol-4-yl)cyclopropane carboxylic acids: key intermediates for H3 histamine receptor ligands
576
Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs Original Research Article
577
Synthesis and biological evaluation of novel 2′-deoxy-4′-thio-imidazole nucleosides Original Research Article
578
Synthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor
579
Synthesis and biological evaluation of novel 2-vinyl carbapenems. Remarkable DHP-1 stability of 1′-substituted analogs
580
Synthesis and biological evaluation of novel 3′-difluorovinyl taxoids
581
Synthesis and biological evaluation of novel 3′-N-tert-butylsulfonyl analogues of docetaxel
582
Synthesis and biological evaluation of novel 4″-alkoxy avermectin derivatives
583
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors Original Research Article
584
Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study Original Research Article
585
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors Original Research Article
586
Synthesis and biological evaluation of novel 8-aminomethylated oroxylin A analogues as α-glucosidase inhibitors
587
Synthesis and biological evaluation of novel 9-functional heterocyclic coupled 7-deoxy-9-Dihydropaclitaxel analogue
588
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine
589
Synthesis and biological evaluation of novel analogues of dictyostatin
590
Synthesis and biological evaluation of novel angularly fused polycyclic coumarins
591
Synthesis and biological evaluation of novel benzoxazinic analogues of ellipticine
592
Synthesis and biological evaluation of novel benzyl piperazine derivatives of 5-(5-nitroaryl)-1,3,4-thiadiazoles as Anti-Helicobacter pylori agents
593
Synthesis and biological evaluation of novel bisheterocycle-containing compounds as potential anti-influenza virus agents
594
Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation
595
Synthesis and biological evaluation of novel bisphosphonates with dual activities on bone in vitro
596
Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents
597
Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors Original Research Article
598
Synthesis and Biological Evaluation of Novel Chalcone-Porphyrin Conjugates
599
Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage
600
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the β-alanine region
601
Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents Original Research Article
602
Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes
603
Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer
604
Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain Original Research Article
605
Synthesis and biological evaluation of novel ethyl 2-amino-6-ferrocenyl-1,6-dihydropyrimidine-5-carboxylates and ethyl 2-amino-6-ferrocenylpyrimidine-5-carboxylates
606
Synthesis and biological evaluation of novel fused triazolo[4,3- a] pyrimidinones
607
Synthesis and biological evaluation of novel heterocyclic ionone-like derivatives as anti-inflammatory agents Original Research Article
608
Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C
609
Synthesis and biological evaluation of novel hexahydro-pyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT2C receptor agonists
610
Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties
611
Synthesis and biological evaluation of novel imidazole-containing macrocycles
612
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists
613
Synthesis and biological evaluation of novel lipid A antagonists Original Research Article
614
Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3β (GSK-3β) inhibitors Original Research Article
615
Synthesis and Biological Evaluation of Novel Mono Acid Esters Derived from the Constituents of Urtica pilulifera
616
Synthesis and biological evaluation of novel neamine–nucleoside conjugates potentially targeting to RNAs
617
Synthesis and biological evaluation of novel PDMP analogues Original Research Article
618
Synthesis and biological evaluation of novel phthalazinone derivatives as topically active phosphodiesterase 4 inhibitors Original Research Article
619
Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors
620
Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors Original Research Article
621
Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents Original Research Article
622
Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy
623
Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors
624
Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters
625
Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors
626
Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors
627
Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents
628
Synthesis and biological evaluation of novel thioapio dideoxynucleosides Original Research Article
629
Synthesis and biological evaluation of novel thio-substituted chromanes as high-affinity partial agonists for the estrogen receptor
630
Synthesis and biological evaluation of novel T-type Ca2+ channel blockers Original Research Article
631
Synthesis and biological evaluation of novel T-type calcium channel blockers
632
Synthesis and biological evaluation of novel turn-modified gramicidin S analogues Original Research Article
633
Synthesis and biological evaluation of novel β-carboline derivatives as Tat–TAR interaction inhibitors
634
Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists
635
Synthesis and biological evaluation of N-thia-carba-thymidine as an antiherpetic agent
636
Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3′-C-ethynyluridine (EUrd) and 3′-C-ethynylcytidine (ECyd) Original Research Article
637
Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents
638
Synthesis and biological evaluation of oligosaccharides related to the molecule signals in plant defence and the Rhizobium-legume symbiosis
639
Synthesis and biological evaluation of one novel technetium-99m-labeled nitroquipazine derivative as an imaging agent for serotonin transporter
640
Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors Original Research Article
641
Synthesis and biological evaluation of ortho-carborane containing benzoxazole as an inhibitor of hypoxia inducible factor (HIF)-1 transcriptional activity
642
Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase Original Research Article
643
Synthesis and biological evaluation of oxazinonaphthalene-3-one derivatives as potential anticancer agents and tubulin inhibitors
644
Synthesis and biological evaluation of PEG-tirofiban conjugates
645
Synthesis and biological evaluation of penam sulfones as inhibitors of β-lactamases Original Research Article
646
Synthesis and biological evaluation of pentacyclo[5.4.0.02,6.03,10.05,9]undecane derivatives as potential therapeutic agents in Parkinsonʹs disease Original Research Article
647
Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor α and β agonists Original Research Article
648
Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum Original Research Article
649
Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists
650
Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human β-secretase (BACE1) Original Research Article
651
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors
652
Synthesis and biological evaluation of phosphonated carbocyclic 2′-oxa-3′-aza-nucleosides Original Research Article
653
Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides Original Research Article
654
Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid
655
Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
656
Synthesis and biological evaluation of platinum(II) complexes containing (1R,2R)-N1-alkyl-1,2-diaminocyclohexane and D-(+)-camphorate ligands
657
Synthesis and biological evaluation of polyhydroxycurcuminoids Original Research Article
658
Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitor Original Research Article
659
Synthesis and biological evaluation of potent glycosidase inhibitors: 4-deoxy-4,4-difluoroisofagomine and analogues
660
Synthesis and biological evaluation of potent glycosidase inhibitors: N-phenyl cyclic isourea derivatives of 5-amino- and 5-amino-C-(hydroxymethyl)-1,2,3,4-cyclopentanetetraols Original Research Article
661
Synthesis and biological evaluation of prodrug-type anti-HIV agents: ester conjugates of carboxylic acid-containing dipeptide HIV protease inhibitors and a reverse transcriptase inhibitor Original Research Article
662
Synthesis and biological evaluation of propargyl acetate derivatives as anti-mycobacterial agents
663
Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors
664
Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors Original Research Article
665
Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents Original Research Article
666
Synthesis and biological evaluation of pyridine-modified analogues of 3-(2-Aminoethoxy)pyridine as novel nicotinic receptor ligands
667
Synthesis and biological evaluation of pyrido[2,3-b]pyrazine and pyrido[2,3-b]pyrazine-n-oxide as selective glycine antagonists
668
Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110α inhibitors
669
Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines Original Research Article
670
Synthesis and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) C8 cyclic amine conjugates
671
Synthesis and biological evaluation of pyrroloiminoquinone derivatives Original Research Article
672
Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth muscle cell proliferation
673
Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4-oxadiazoles for detecting β-amyloid plaques in the brain Original Research Article
674
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors
675
Synthesis and biological evaluation of RON-neoglycosides as tumor cytotoxins Original Research Article
676
Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway Original Research Article
677
Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand Original Research Article
678
Synthesis and biological evaluation of SGLT2 inhibitors: gem-difluoromethylenated Dapagliflozin analogs
679
Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents Original Research Article
680
Synthesis and biological evaluation of simplified mycothiazole analogues
681
Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents
682
Synthesis and biological evaluation of some 6-arylamidomorphines as analogues of morphine-6-glucuronide Original Research Article
683
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME BENZIMIDAZO-1,2,4-TRIAZOLE DERIVATIVES AS ANTIMICROBIAL AND ANTI-INFLAMMATORY AGENTS
684
Synthesis and biological evaluation of some N-ethoxyphthalimido-4-phenyl-6- subsitutedphenyl-2,3a,4,5-tetrahydro-3H-indazol-3-one via Robinson annulations reaction
685
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW COUMARIN DERIVATIVES AS ANTIMICROBIAL AGENTS
686
Synthesis and Biological Evaluation of some new Imidazo[1,2-a]pyridines
687
Synthesis and Biological Evaluation of Some New Thienopyridine and Thienopyrimidine Derivative
688
Synthesis and Biological Evaluation of Some Newer 1H-Benzo[b][1,5]diazepin-2(3H)-one Derivatives as Potential Anticonvulsant Agents
689
Synthesis and biological evaluation of some novel 4′-Thio- -ribonucleosides with modified nucleobase moieties
690
Synthesis and biological evaluation of some novel furan derivatives
691
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME SCHIFF BASES OF [4-(AMINO) -5- PHENYL- 4H-1, 2, 4-TRIAZOLE- 3- THIOL]
692
Synthesis and biological evaluation of sperm CD52 GPI anchor and related derivatives as binding receptors of pore-forming CAMP factor Original Research Article
693
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs Original Research Article
694
Synthesis and biological evaluation of spongistatin/altohyrtin analogues: E-ring dehydration and C46 side-chain truncation
695
Synthesis and biological evaluation of stilbene-based pure estrogen antagonists
696
Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors Original Research Article
697
Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers
698
Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors
699
Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents Original Research Article
700
Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
701
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110α inhibitors Original Research Article
702
Synthesis and biological evaluation of taxinine analogues as orally active multidrug resistance reversal agents in cancer
703
Synthesis and Biological Evaluation of Tc-99mCyclopentadienyltricarbonyltechnetium-Labeled Octreotide
704
Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor
705
Synthesis and biological evaluation of the disulfide form of the glutathione analogue γ-(l-glutamyl)-l-cysteinyl-l-aspartyl-l-cysteine
706
Synthesis and biological evaluation of the first example of an eight-membered iminoalditol
707
Synthesis and Biological Evaluation of the Four Isomers of Technetium-99m. Labeled Ethylenecysteamine Cysteine (99mTc-ECC), the Mono-acid Derivative of 99mTc-L,L-ethylenedicysteine
708
Synthesis and biological evaluation of the L-enantiomer of 2′-deoxy-5-ethyl-4′-thiouridine
709
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect
710
Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one Original Research Article
711
Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) β-glucuronide and β-galactoside for application in selective prodrug chemotherapy
712
Synthesis and biological evaluation of the Zn (II)–IDB complexes appended with oligopolyamide as potent artificial nuclease
713
Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation
714
Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli β-ketoacyl-ACP-synthase III (FabH)
715
Synthesis and biological evaluation of thiobenzanilides as anticancer agents Original Research Article
716
Synthesis and Biological Evaluation of Thiosemicarbazide Derivatives Endowed with High Activity toward Mycobacterium Bovis
717
Synthesis and biological evaluation of thymine nucleosides fused with 3′,4′-tetrahydrofuran ring
718
Synthesis and biological evaluation of trehalose analogs as potential inhibitors of mycobacterial cell wall biosynthesis Original Research Article
719
Synthesis and biological evaluation of triazepane derivatives as DPP-IV inhibitors
720
Synthesis and biological evaluation of triazole analogues of antillatoxin
721
Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents Original Research Article
722
Synthesis and biological evaluation of trimethyl-substituted cap analogs
723
Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38α mitogen-activated protein kinase
724
Synthesis and biological evaluation of two analogues of (S)-α-methyl-3-carboxyphenylalanine
725
Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV
726
Synthesis and biological evaluation of two new radiolabelled estrogens: [125I](E)-3-methoxy-17α-iodovinylestra-1,3,5(10),6-tetraen-17β-ol and [125I](Z)-3-methoxy-17α-iodovinylestra-1,3,5(10),6-tetraen-17β-ol
727
Synthesis and biological evaluation of two novel 2′-substituted tiazofurin analogues
728
Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine
729
Synthesis and biological evaluation of type VI β-turn templated RGD peptidomimetics
730
Synthesis and biological evaluation of unnatural canthine alkaloids
731
Synthesis and biological evaluation of unprecedented classes of spiro-β-lactams and azido-β-lactams as acyl-CoA:cholesterol acyltransferase inhibitors
732
Synthesis and biological evaluation of ureido and thioureido derivatives of 2-amino-2-deoxy-d-glucose and related aminoalcohols as N-acetyl-β-d-hexosaminidase inhibitors
733
Synthesis and biological evaluation of α- and γ-carboxamide derivatives of 10-CF3CO-DDACTHF Original Research Article
734
Synthesis and biological evaluation of α,α-difluorobenzylphosphonic acid derivatives as small molecular inhibitors of protein-tyrosine phosphatase 1B
735
Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3)
736
Synthesis and biological evaluation of α-mannosidase inhibitory activity of three deoxy derivatives of mannostatin A
737
Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists Original Research Article
738
Synthesis and biological evaluation of γ-fluoro-β,γ-unsaturated acids
739
Synthesis and Biological Evaluation Schiff Bases of Fatty Hydrazides from Nontraditional Oils
740
Synthesis and Biological Evaluation Schiff Bases of Fatty Hydrazides from Nontraditional Oils
741
Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents
742
Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents
743
Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 Original Research Article
744
Synthesis and biological evaluations of condensed pyridine and condensed pyrimidine-based HMG-CoA reductase inhibitors
745
Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents
746
Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors Original Research Article
747
Synthesis and biological evaluations of some Schiff-base esters of ferrocenyl aniline and simple aniline
748
Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
749
Synthesis and biological identification of the acyl glucuronide of the antiinflammatory drug ML-3000
750
Synthesis and biological investigation of new 4″-malonyl tethered derivatives of erythromycin and clarithromycin
751
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors
752
Synthesis and Biological Investigation of some Novel Sulfonamide and Amide Derivatives Containing Coumarin Moieties
753
Synthesis and biological investigations of [18F]MR18445, a 5-HT3 receptor partial agonist Original Research Article
754
Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype
755
Synthesis and Biological Potentials of Novel Benzodipyrone-Based Derivatives
756
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1α-hydroxyvitamin D3-26,23-lactones—weak agonists Original Research Article
757
Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2-ylthio)carbapenems Original Research Article
758
Synthesis and biological properties of a series of optically active 2-oxaisocephems Original Research Article
759
Synthesis and Biological Properties of Amino Acid Amide Ligand-Based Pyridinioalkanoyl Thioesters as Anti-HIV Agents Original Research Article
760
Synthesis and biological properties of C12,13-cyclopropylepothilone A and related epothilones Original Research Article
761
Synthesis and biological properties of carboranylaziridines bearing cascade polyols
762
Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold Original Research Article
763
Synthesis and biological properties of new 1β-methylcarbapenems
764
Synthesis and biological properties of new 1β-methylcarbapenems containing heteroaromatic thioether moiety
765
Synthesis and biological properties of new 1β-methylcarbapenems having tetrazolothioether moiety
766
Synthesis and biological properties of new 5-nitroindazole derivatives Original Research Article
767
Synthesis and biological properties of new glycosidic cationic lipids for DNA delivery
768
Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters Original Research Article
769
Synthesis and biological properties of novel sphingosine derivatives
770
Synthesis and biological properties of partially modified retro and retro-inverso pseudo peptides of arg-gly-asp (RGD)
771
Synthesis and biological properties of substituted 1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acids Original Research Article
772
Synthesis and biological properties of tensyuic acids B, C, and E, and investigation of the optical purity of natural tensyuic acid B
773
Synthesis and Biological Properties of Zinc(II) Complexes of some 2-hydroxyacetophenone-benzoylhydrazones
774
Synthesis and biological properties of β-turned Aβ31–35 constrained analogues
775
Synthesis and biological property of carba and 20-Deoxo analogues of arenastatin A
776
Synthesis and biological relationships of 3′,6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents Original Research Article
777
Synthesis and biological response of casein-based silica nano-composite film for drug delivery system
778
Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia
779
Synthesis and Biological Screening of 1,3-Dialkyl Derivatives of 4-(2’5-Dioxopyrrolidine-3-yl) Phenyl Sulphinic Acid as Inhibitors of Oestrone Sulphatase
780
Synthesis and biological screening of a combinatorial library of β-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents Original Research Article
781
Synthesis and Biological Significance of Some 2-Azetidinone Derivatives
782
Synthesis and Biological Significance of Some 2-Azetidinone Derivatives
783
Synthesis and Biological Significance of Some 2-Azetidinone Derivatives
784
Synthesis and biological studies for some heterocyclic compounds derived from 2-Morpholino-1,8- naphthyridine-4-carboxylic acid
785
Synthesis and biological studies of 1-amino β-carbolines
786
Synthesis and biological studies of flexible brevetoxin/ciguatoxin models with marked conformational preference
787
Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents Original Research Article
788
Synthesis and Biological Studies of Novel Neurotensin(8–13) Mimetics Original Research Article
789
Synthesis and biological studies of steroidal pyran based derivatives
790
Synthesis and biological studies of yohimbine derivatives on human α2C-adrenergic receptors
791
Synthesis and biological study of 2-amino-4-aryl-5-chloropyrimidine analogues as inhibitors of VEGFR-2 and cyclin dependent kinase 1 (CDK1)
792
Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists Original Research Article
793
Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitors
794
Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe Original Research Article
795
Synthesis and Biological Study of Novel Bis-chalcones, Bis-thiazines and Bispyrimidines
796
Synthesis and biological study of some amino acid functionalized starch-graft-polyacrylamide
797
Synthesis and Biological Study of Some New Derivatives of Sesquiterpene Lactones Isolated from Medicinal Plants
798
Synthesis and Biological Study of Some Transition Metal Ions Complexes of Schiff-Mannich Base Derived from 2-Amino-5- Mercpto-1,3,4 Thiadiazole
799
Synthesis and Biological Study of Substituted 2”-Hydoxy, 2”,4”-dichloro Chalcones and Their Co(II), Cu(II) and Ni(II) Complexes for Their Antioxidant and Antimicrobial Potentials
800
Synthesis and Biological Testing of Acyl-CoA–Ketoprofen Conjugates as Selective Irreversible Inhibitors of COX-2 Original Research Article
801
Synthesis and biological testing of non-Fluorinated analogues of levofloxacin
802
Synthesis and biological testings as inhibitors of HMGCoA reductase of the seco-acid of tuckolide and its C-7 epimer Original Research Article
803
Synthesis and Biologically Activity of Novel 2- Chloro -3-Formyl -1,5-Naphthyridine Chalcone Derivatives
804
Synthesis and biology of 3′-N-acyl-N-debenzoylpaclitaxel analogues Original Research Article
805
Synthesis and biology of N-thiolated β-lactams
806
Synthesis and biology of the rigidified glutamate analogue, trans-2-carboxyazetidine-3-acetic acid (t-CAA)
807
Synthesis and Biomedical Activities of Coumarins Derived From Natural Phenolic Acids
808
Synthesis and biomedical activities of novel multifunctional benzodipyrone-based derivatives
809
Synthesis and bioorthogonal coupling chemistry of a novel cyclopentenone-containing unnatural tyrosine analogue
810
Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin Original Research Article
811
Synthesis and biophysical studies of oligonucleotides containing hydroxamate linkages
812
Synthesis and biosensing application of highly water-soluble and cross-linkable poly(p-phenyleneethynylene) containing osmium(II) complex and aldehyde groups Original Research Article
813
Synthesis and Biosynthesis of Oligomeric Sebacates as Lubricant Oils
814
Synthesis and Biotransformation of Some Halogenated Steroids by the Fungus Mucor plumbeus
815
Synthesis and biotransformation of some steroidal imines by the fungus Mucor plumbeus
816
Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones
817
Synthesis and blood compatibility evaluation of segmented polyurethanes based on cholesterol and phosphatidylcholine analogous moieties
818
Synthesis and blue luminescence of a soluble newly designed carbazole main-chain polymer
819
Synthesis and blue to near-infrared quantum cutting of Pr3+/Yb3+ co-doped Li2TeO4 phosphors
820
Synthesis and blue-violet two-photon excited fluorescence of a new organoboron compound
821
Synthesis and bonding of trans-dichlorobis(1,3-diaminopropane)ruthenium(III) chloride to a self assembled monolayer and its effect on conducting polymer sheet conductivity
822
Synthesis and bradykinin inhibitory activity of novel non-peptide compounds, and evaluation of in vivo analgesic activity Original Research Article
823
Synthesis and bright luminescence of lanthanide (Eu(III), Tb(III)) complexes sensitized with a novel organic ligand
824
Synthesis and brittle-to-ductile transition of the ω-Al0.7Cu0.2Fe0.1 tetragonal phase
825
Synthesis and bromination of 4-alkylamino-N-alkyl1,8-naphthalimides
826
Synthesis and bulk organization of polymer nanocomposites based on hemi/ditelechelic poly(propylene oxide) end-functionalized with POSS cages
827
Synthesis and bundle-like assemblies of LaPO4 nanofibers in reverse micelles system
828
Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. part 1: study of the structural features for BZR recognition Original Research Article
829
Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons Original Research Article
830
Synthesis and Calcium Channel Antagonist Activities of New Derivatives of Dialkyl 1,4-Dihydro-2,6-dimethyl-4-(5-phenylisoxazol-3-yl)pyridine-3,5-dicarboxylates
831
Synthesis and Calcium Channel Blocking Activity of 1, 4-Dihydropyridine Derivatives Containing Ester Substitute and Phenyl Carbamoyl Group
832
Synthesis and Calcium Channel Blocking Activity of 4-Indolyl-1,4-dihydropyridines
833
Synthesis and calorimetric study of rare earth complexes [RE(C3H7NO2)2(C3H4N2)(H2O)](ClO4)3 (RE: Sm, Eu, Dy, Er)
834
Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position
835
Synthesis and calpain inhibitory activity of α-ketoamides with 2,3-methanoleucine stereoisomers at the P2 position
836
Synthesis and cancer cell cytotoxicity of substituted xanthenes Original Research Article
837
Synthesis and capacitive performance of nitrogen doped porous carbons derived from sodium carboxymethyl starch
838
Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites Original Research Article
839
Synthesis and carbohydrate binding studies of fluorescent α-amidoboronic acids and the corresponding bisboronic acids Original Research Article
840
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography
841
Synthesis and carbonization chemistry of a phosphorous–nitrogen based intumescent flame retardant
842
Synthesis and cardiac effects of 3,4-dihydropyrimidin-2(1H)-one-5 carboxylates
843
Synthesis and cardio protective biological applications of glucodendrimers by H9C2 cell studies
844
Synthesis and cardiovascular activity of metoprolol analogues
845
Synthesis and cascade reactions of diallenyl α-disulfones and sulfinyl sulfones
846
Synthesis and catalysis of nanometer-sized bimodal mesoporous aluminosilicate materials
847
Synthesis and catalysis of tungsten oxide in hexagonal mesoporous silicas (W-HMS) Original Research Article
848
Synthesis and catalytic activities of copper(II) complexes derived from a tridentate pyrazole-containing ligand. X-ray crystal structure of [Cu2(μ-dpzhp-O,N,N′)2][Cu(MeOH)Cl3]2
849
Synthesis and catalytic activities of PdII–phosphine complexes modified poly(ether imine) dendrimers
850
Synthesis and catalytic activity in ethylene polymerization of cyclopentadienylterbium dibromides with pyrazole or triphenylphosphine ligand
851
Synthesis and catalytic activity of a chiral periodic mesoporous organosilica (ChiMO)
852
Synthesis and catalytic activity of a fluorous-tagged TEMPO radical
853
Synthesis and catalytic activity of Au-supported porous TiO2 nanospheres for CO oxidation
854
Synthesis and catalytic activity of camphor titanium complexes
855
Synthesis and catalytic activity of DAB-dendrimer encapsulated Pd nanoparticles for the Suzuki coupling reaction
856
Synthesis and catalytic activity of doped TiO2-palygorskite composites
857
Synthesis and catalytic activity of manganese dioxide (type OMS-2) for the abatement of oxygenated VOCs
858
Synthesis and catalytic activity of neutral salicylaldiminato nickel(II) complexes bearing a single N-heterocyclic carbene ligand
859
Synthesis and catalytic activity of N-heterocyclic carbene silver complexes derived from 1-[2-(pyrazol-1-yl)phenyl]imidazole
860
Synthesis and catalytic activity of Ni°-acid activated montmorillonite nanoparticles
861
Synthesis and catalytic activity of novel Zn–N and Cu–N complexes
862
Synthesis and catalytic activity of organometallic complexes of palladium(II) with bis-phosphine monosulfides towards ethylene/CO copolymerization
863
Synthesis and catalytic activity of Pt monolayer on Pd tetrahedral nanocrystals with CO-adsorption-induced removal of surfactants
864
Synthesis and catalytic activity of rhodium diene complexes bearing indenyl-type fullerene η5-ligand
865
Synthesis and catalytic activity of ruthenium(II) complexes containing pyridine-based tridentate triamines () and pyridine carboxylate ligands ()
866
Synthesis and catalytic activity of Ti-MCM-41 nanoparticles with highly active titanium sites
867
Synthesis and catalytic application of monometallic molybdenum(IV) nitrile complexes
868
Synthesis and catalytic application of nanofibrous La0.9A0.1MnO3 (A = Ca, Cu, Ag) with macroscopic shapes
869
Synthesis and catalytic application of Pd nanoparticles in graphite oxide Original Research Article
870
Synthesis and catalytic application of zirconium-substituted aminoethyl phosphonate
871
Synthesis and catalytic applications of metal–organic frameworks: a review on recent literature
872
Synthesis and catalytic applications of new chiral ferrocenyl P,O ligands
873
Synthesis and catalytic applications of sulfonate β-ketoimine and β-diimine in the Suzuki reaction in aqueous phase
874
Synthesis and catalytic behaviors of cobalt nanocrystals with special morphologies
875
Synthesis and catalytic behaviour of heterogenized rhodium catalysts on modified clays Original Research Article
876
Synthesis and catalytic evaluation of a ruthenium alkylidene complex bearing methoxy-pyridine ligand Original Research Article
877
Synthesis and catalytic performance for olefin epoxidation of a novel dioxomolybdenum (VI) (ferrocenylmethyleneamino)alcoholate complex
878
Synthesis and Catalytic Performance of Ni/Silica Pillared Clay on HDPE Plastic Hydrocracking to Produce Liquid Hydrocarbons as Fuel
879
Synthesis and catalytic properties of a new titanosilicate molecular sieve with the structure analogous to MWW-type lamellar precursor
880
Synthesis and catalytic properties of a new window type hybrid porous zirconium phosphonate
881
Synthesis and catalytic properties of cationic palladium(II) and rhodium(I) complexes bearing diphosphinidinecyclobutene ligands
882
Synthesis and catalytic properties of CeO2 and Co/CeO2 nanofibres for diesel soot combustion
883
Synthesis and catalytic properties of diverse chiral polyamines
884
Synthesis and catalytic properties of highly ordered mesostructured silica-pillared α-zirconium phosphate: Self-assembly via interlayered templating method
885
Synthesis and catalytic properties of mesoporous phosphotungstic acid/SiO2 in a self-generated acidic environment by evaporation-induced self-assembly
886
Synthesis and catalytic properties of microemulsion-derived cerium oxide nanoparticles
887
Synthesis and catalytic properties of nano CuO prepared by soft chemical method
888
Synthesis and catalytic properties of nanostructured aluminas obtained by sol–gel method Original Research Article
889
Synthesis and catalytic properties of neutral and cationic rhodium- and iridium-containing carbosilane dendrimers
890
Synthesis and catalytic properties of novel POM@TiO2 composite materials
891
Synthesis and catalytic properties of novel ruthenium N-heterocyclic-carbene complexes
892
Synthesis and catalytic properties of porous Nb–Mo oxide solid acid
893
Synthesis and catalytic properties of thermally and hydrothermally stable, high-surface-area SiO2–CeO2 mesostructured composite materials and their application for the removal of sulfur compounds from gasoline
894
Synthesis and catalytic properties of TS-1 with mesoporous/microporous hierarchical structures obtained in the presence of amphiphilic organosilanes
895
Synthesis and catalytic properties of vanadium interstitial compounds Original Research Article
896
Synthesis and catalytic property of poly(styrene-co-divinylbenzene) supported ruthenium(III)-2-aminopyridyl complexes
897
Synthesis and cathodoluminescence of Sb/P co-doped GaN nanowires
898
Synthesis and cathodoluminescence properties of porous wood (fir)-templated zinc oxide
899
Synthesis and cathodoluminescent properties of Y2SiO5:Tb3+ phosphors prepared from uniform precursor
900
Synthesis and Cation Binding Properties by 5,11,17,23-Tetra(Tert-Butyl)-25,27-Bis(Ethoxymethoxy)-26,28-Bis(Diethylaminocarbonylmethoxy)calix [4] Arene
901
Synthesis and Cation Binding Properties by 5,11,17,23-Tetra(Tert-Butyl)-25,27-Bis(Ethoxymethoxy)-26,28-Bis(Diethylaminocarbonylmethoxy)calix[4]Arene
902
Synthesis and cation binding properties of new arylazo- and heteroarylazotetrathiacalix[4]arenes
903
Synthesis and cation complexation properties of new macrolides
904
Synthesis and cation complexation studies of a new tetra(2-pyridylmethyl)amide calix[4]arene
905
Synthesis and cation distribution of copper-substituted spinel-related lithium ferrite Original Research Article
906
Synthesis and cation exchange properties of a new porous cation exchange resin having an open-celled monolith structure
907
Synthesis and cation-extraction study of chromogenic 14-crown-4 derivatives for spectrophotometric determination of lithium Original Research Article
908
Synthesis and cationic ordering structure of samarium-doped lead magnesium niobate ceramics
909
Synthesis and cationic photocuring of new carbazole monomers
910
Synthesis and cationic photopolymerization of a new fluorinated oxetane monomer
911
Synthesis and cationic polymerization of 5-(2,3-epoxypropyl)amino-2-phenyl-1,2,3-benzotriazole
912
Synthesis and cationic polymerization of oxyranyl-functionalized triphenylamine
913
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE) Original Research Article
914
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives
915
Synthesis and CD spectroscopy of polyethers with homochiral and heterochiral layers of stereocentres
916
Synthesis and CD structural studies of CD52 peptides and glycopeptides Original Research Article
917
Synthesis and cell activity of novel galactosylated chitosan as a gene carrier
918
Synthesis and cell affinity of functionalized poly( -lactide-co-β-malic acid) with high molecular weight
919
Synthesis and cell cycle inhibition of the peptide enamide natural products terpeptin and the aspergillamides
920
Synthesis and cell growth inhibitory properties of substituted (E)-1-phenylbut-1-en-3-ones
921
Synthesis and cell phototoxicity of a triply bridged fused diporphyrin appended with six thioglucose units
922
Synthesis and Cell Seeding Assessment of Novel Biphasic Nano Powder in the CaO–MgO–SiO2 System for Bone Implant Application
923
Synthesis and cell transfection properties of cationic uracil-morpholino tetramer
924
Synthesis and cell uptake of a novel dualmodality 188Re-HGRGD (D) F-CdTe QDs probe
925
Synthesis and cellular characterization of the detransformation agent, (−)-depudecin Original Research Article
926
Synthesis and cellular compatibility of biomineralized Fe3O4 nanoparticles in tumor cells targeting peptides
927
Synthesis and cellular compatibility of Co-doped ZnO particles in silk-fibroin peptides
928
Synthesis and cellular effects of cycloterpenals: Cyclohexadienal-based activators of neurite outgrowth Original Research Article
929
Synthesis and cellular properties of Near-IR BODIPY–PEG and carbohydrate conjugates
930
Synthesis and cellular studies of a carboranylchlorin for the PDT and BNCT of tumors Original Research Article
931
Synthesis and cellular studies of an octa-anionic 5,10,15,20-tetra[3,5-(nido-carboranylmethyl)phenyl]porphyrin (H2OCP) for application in BNCT Original Research Article
932
Synthesis and cellular studies of PEG-functionalized meso-tetraphenylporphyrins
933
Synthesis and cellular uptake of a fluorescently labeled cyclic PNA-based compound
934
Synthesis and cellular uptake of cell delivering PNA–peptide conjugates
935
Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles—a potential candidate for bimodal anticancer therapy
936
Synthesis and cellular uptake of scatteredly cyclic RGDfK-conjugated superparamagnetic iron oxide nanoparticles
937
Synthesis and ceramic conversion of a novel processible polyboronsilazane precursor to SiBCN ceramic
938
Synthesis and Ceramic Conversion of Polysiloxazane to Silicon Oxynitride
939
Synthesis and chain length–anti-HIV activity relationship of fully N- and O-sulfated homooligomers of tyrosine Original Research Article
940
Synthesis and Character ation of Novel (Co (II), Ni{11 , .cuM, Zn en , and Cd(ll)) Binuclear Complexes of N, N- his [(2, 4, 6-trihydroxy metbyl)] Benzidine
941
Synthesis and character of super-hydrophobic CaCO3 powder in situ
942
Synthesis and characterisation a series of N-(3,4-dichlorophenyl)-N′-(2,3 and 4-methylbenzoyl)thiourea derivatives
943
Synthesis and characterisation of [[μ-(1,7,11,17-tetraaza-2,6,12,16-tetraoxacycloeicosane)][(μ-(aquo)]bis[(acac)(ethanol)nickel(II)]] [BPh4]2
944
Synthesis and characterisation of [AlMen{Si(SiMe3)3}3−n(thf)] (n = 1 or 2)
945
Synthesis and characterisation of [Fe2M3(μ4-E)(μ3-E′)(CO)17] and [Os3(μ3-E)(μ3-E′)(CO)9] (M=Os or Ru; E=S, Se, Te; E′=Se, Te)
946
Synthesis and characterisation of [M(η5-NC4Me4)(CH2Ph)3] (M=Ti, Zr, Hf) and [Ti(η5-NC4Me4)(Me)Cl2]. Structural determination and bonding of [Ti(η5-NC4Me4)(Me)Cl2] depicting an agostic interaction
947
Synthesis and characterisation of [Pt2(μ-S)(μ-I)(PPh3)4]+ – A cationic iodo analogue of the metalloligand [Pt2(μ-S)2(PPh3)4]
948
Synthesis and characterisation of 3- and 4-(pentafluorosulfanyl)benzoic acid derivatives: X-ray structure of 3–SF5–C6H4–COOH
949
Synthesis and characterisation of 3-aza-7-phosphabicyclo[3.3.1]nonan-9-ones
950
Synthesis and characterisation of 5,11,17,23,29-penta(tert-butyl)-32,33,35-tri[((1S)-camphor-10-sulfonyl)-oxy]-34,36-dihydroxy-calix[5]arene
951
Synthesis and characterisation of 5,11,17,23,29-penta(tert-butyl)-32,33,35-tri[((1S)-camphor-10-sulfonyl)-oxy]-34,36-dihydroxy-calix[5]arene
952
Synthesis and characterisation of 5,11,17,23,29-penta(tert-butyl)-32,33,35-tri[((1S)-camphor-10-sulfonyl)-oxy]-34,36-dihydroxy-calix[5]arene
953
Synthesis and characterisation of 8-hydroxyquinoline–bovine serum albumin conjugates as metal ion chelating proteins Original Research Article
954
Synthesis and characterisation of a {Ni21Ag} cage
955
Synthesis and characterisation of a {Ni8} single molecule magnet and another octanuclear nickel cage
956
Synthesis and characterisation of a bis(silyloxy)tin(IV) porphyrin
957
Synthesis and Characterisation of a Dioxo-(mu)-Oxo Molybdenum Dimer: An Unusual case of a (mu)-Oxo Conformational Equilibrium
958
Synthesis and characterisation of a diphosphaalkene, a diphosphaalkyne and the first diphosphavinyl lithium complex
959
Synthesis and characterisation of a green NiO/La(Sr)PO4−δ cermet anode for phosphate based solid oxide fuel cells
960
Synthesis and characterisation of a mesoporous carbon/calcium borohydride nanocomposite for hydrogen storage
961
Synthesis and characterisation of a nematic homo-polyurethane
962
Synthesis and characterisation of a new amphotericin b–methoxypoly(ethylene glycol) conjugate
963
Synthesis and characterisation of a new class of phosphine-phosphonite ferrocenediyl dinuclear rhodium complexes
964
Synthesis and characterisation of a new composite aluminosilicate bioceramic
965
Synthesis and characterisation of a new helically chiral ruthenium complex
966
Synthesis and characterisation of a new high pressure polymorph of Cu2WS4
967
Synthesis and characterisation of a new naphthalene tris-Tröger’s base derivative—a chiral molecular clip
968
Synthesis and characterisation of a new pH-sensitive amphotericin B—poly(ethylene glycol)-b-poly(l-lysine) conjugate
969
Synthesis and characterisation of a new podand based on a calixarene and a β-lactam
970
Synthesis and characterisation of a new polycyclic phenazine from 1,4-naphthoquinone
971
Synthesis and characterisation of a new stable organo-mineral hybrid nanomaterial: 4-Chlorobenzenesulfonate in the zinc–aluminium layered double hydroxide
972
Synthesis and characterisation of a new sulphonated hydrocarbon polymer for application as a solid proton-conducting electrolyte
973
Synthesis and characterisation of a new superelastic Ti–25Ta–25Nb biomedical alloy
974
Synthesis and characterisation of a new vanadyl oxalatophosphate compound: (C10H10N2)[(VO)(HPO4)]2(C2O4)
975
Synthesis and Characterisation of a Novel 2,3-O-di Acetyl- 5,6-O-Benzylidene - L -Ascorbic Acid and its Complexes of Cr(III), Co(II), Ni(II),Cu(II) and Zn(II)
976
Synthesis and characterisation of a novel europium-based graphite intercalation compound
977
Synthesis and characterisation of a novel surfactant, sodium geranyl sulphate
978
Synthesis and characterisation of a potential ceramic sulfide ion conductor based on the solid solution xCaS:Nd2S3, x = 0.7–1.0
979
Synthesis and characterisation of a pseudohalide derivative of Au–Pd cluster compound: X-ray crystal and molecular structure of [(dmpi)2Pd(AuPPh3)6](NO3)2
980
Synthesis and characterisation of a ruthenocenoyl bioconjugate with the cyclic octapeptide octreotate
981
Synthesis and characterisation of a series of 1,2-phenylenedioxoborylcyclopentadienyl–metal complexes [Ti(IV), Zr(IV), Hf(IV), La(III), Ce(III), Yb(III), Sn(II) and Fe(II)]
982
Synthesis and characterisation of a series of mononuclear ruthenium(II) carbonyl complexes of heterocycle-based asymmetric bidentate ligands
983
Synthesis and characterisation of a trinuclear uranyl complex: Crystal structure of (CN3H6)5[(UO2)3O(OH)2(CH3COO)(C2O4)3]
984
Synthesis and characterisation of adducts of [Pt2(μ-S)2(PPh3)4] with organo-palladium and platinum-hydride substrates
985
Synthesis and characterisation of advanced UHMWPE/silver nanocomposites for biomedical applications
986
Synthesis and characterisation of aluminium and magnesium complexes supported by pendant oxalic amidinate ligands
987
Synthesis and characterisation of ammonium mediated assembly of two neutral nickel(II) Schiff base fragments
988
Synthesis and characterisation of anthracene-based fluorophore and its interactions with selected metal ions
989
Synthesis and characterisation of aromatic ethynyl-bridged ferrocenes
990
Synthesis and characterisation of BaCeO3-based proton conductors obtained from freeze-dried precursors
991
Synthesis and Characterisation of Bimetallic Decorated with Graphene Oxide Nanocomposite as an Outstanding Adsorbent Material in the Removal of Methylene Blue
992
Synthesis and Characterisation of Bimetallic Pd–Rh/Alumina Combustion Catalysts
993
Synthesis and characterisation of bis(2,2′-bipyridine)(4-carboxy-4′-(pyrid-2-ylmethylamido)-2,2′-bipyridine)ruthenium(II) di(hexafluorophosphate): Comparison of spectroelectrochemical properties with related complexes
994
Synthesis and characterisation of bis(amino)silylene–nickel(0), –palladium(II), –platinum(0), –platinum(II) and copper(I) complexes
995
Synthesis and characterisation of bis(pentafluorophenyl)antimony(V) cations, [(C6F5)2SbL3]3+
996
Synthesis and characterisation of bismuth phosphate-based sillenites
997
Synthesis and characterisation of bismuth(III) phthalocyaninate complex: [BiPc]4[Bi6I11Cl11]
998
Synthesis and characterisation of bismuth(III) vanadate
999
Synthesis and characterisation of bonded mercaptopropyl silica intermediate stationary phases prepared using multifunctional alkoxysilanes in supercritical carbon dioxide as a reaction solvent
1000
Synthesis and characterisation of C60 and C70molecular complexes with metal tetraphenylporphyrins MTPP, where M = Mn, Co, Cu, Zn
